Samsung has launched a clinical study to explore how smartwatch data can mitigate muscle mass loss in adults receiving GLP-1 therapy.
Adults with overweight or obesity taking the new generation of weight loss drugs semaglutide and tirzepatide tend to eat significantly less, leaving them vulnerable to nutritional deficiencies, ...
10d
Samsung is using Galaxy Watch 8 to study what Ozempic, other GLP-1 drugs might secretly do to you
Samsung is using the Galaxy Watch 8 to examine users of Ozempic and other GLP-1 weight-loss drugs and offer personalized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results